Use of Neuromuscular Blocking Agents and Neuromuscular Monitoring in 7 Danish Teaching Hospitals - a Cross-sectional Study

Trial Profile

Use of Neuromuscular Blocking Agents and Neuromuscular Monitoring in 7 Danish Teaching Hospitals - a Cross-sectional Study

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Oct 2017

At a glance

  • Drugs Cisatracurium besilate (Primary) ; Mivacurium chloride (Primary) ; Neostigmine (Primary) ; Rocuronium bromide (Primary) ; Sugammadex (Primary) ; Suxamethonium chloride (Primary)
  • Indications Neuromuscular blockade
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Oct 2017 Status changed from recruiting to completed.
    • 22 Feb 2017 Planned primary completion date changed from 1 Jan 2017 to 1 May 2017.
    • 22 Feb 2017 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top